Evidence map›Paper›PMID 36289079›Full record

ArticleAnnals of hematology2022

Successful treatment of MDR Stenotrophomonas maltophilia-associated pneumonia with cefiderocol-based regimen in a patient with hematological malignancy.

Emanuela Zappulo, Francesco Grimaldi, Rossella Paolillo, Biagio Pinchera, Antonio Riccardo Buonomo, Marco Picardi, Maria Rosaria Catania, Fabrizio Pane, Ivan Gentile

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Annals of hematology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.9field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Cefiderocol treatment for patients infected by Stenotrophomonas maltophilia, Burkholderia cepacia complex and Achromobacter spp.: subgroup analysis from the PERSEUS study.European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology · 2025
    Observational
  3. Successful Treatment of PersistentOpen forum infectious diseases · 2023
    Article
  4. New Approaches to Manage Infections in Transplant Recipients: Report From the 2023 GTI (Infection and Transplantation Group) Annual Meeting.Transplant international : official journal of the European Society for Organ Transplantation · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Emanuela ZappuloDepartment of Clinical Medicine and Surgery, Infectious Diseases Unit, University of Naples Federico II, Naples, Italy.
Francesco GrimaldiDepartment of Clinical Medicine and Surgery, Hematology Unit, University of Naples Federico II, Naples, Italy. grimaldi.francesco@gmail.com.ORCID 0000-0003-4365-9406
Rossella PaolilloDepartment of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.
Biagio PincheraDepartment of Clinical Medicine and Surgery, Infectious Diseases Unit, University of Naples Federico II, Naples, Italy.
Antonio Riccardo BuonomoDepartment of Clinical Medicine and Surgery, Infectious Diseases Unit, University of Naples Federico II, Naples, Italy.
Marco PicardiDepartment of Clinical Medicine and Surgery, Hematology Unit, University of Naples Federico II, Naples, Italy.
Maria Rosaria CataniaDepartment of Molecular Medicine and Medical Biotechnologies, University of Naples Federico II, Naples, Italy.
Fabrizio PaneDepartment of Clinical Medicine and Surgery, Hematology Unit, University of Naples Federico II, Naples, Italy.
Ivan GentileDepartment of Clinical Medicine and Surgery, Infectious Diseases Unit, University of Naples Federico II, Naples, Italy.
University of Naples Federico II · ITFederico II University Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gram-Negative Bacterial InfectionsHematologic NeoplasmsPneumoniaStenotrophomonas maltophiliaAnti-Bacterial AgentsCefiderocolCephalosporinsHumansAnti-Bacterial AgentsCefiderocolCephalosporins

Identifiers

PMID36289079
OpenAlexW4307431856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.